TIVC
Tivic Health Systems Inc

4,783
Loading...
Loading...
News
all
press releases
Tivic Receives Two Investigational New Drug Applications for Entolimod for the Treatment of Acute Radiation Syndrome (ARS) and Advanced Cancers
Tivic Health Systems, Inc. (Nasdaq: TIVC), a diversified immunotherapeutics company, today announced it has received, from Statera Biopharma, two investigational new drug applications (INDs) for its...
Business Wire·29d ago
News Placeholder
More News
News Placeholder
Tivic Health Advances Discussions on Use of Entolimod as a Radiation Countermeasure at Military Health System Research Symposium 2025
Tivic Health Systems, Inc. (Nasdaq: TIVC), a diversified therapeutics company, is proud to announce it advanced discussions with key US Government agencies through its participation in the 2025...
Business Wire·1mo ago
News Placeholder
Tivic Health Stock Doubles After Briefings To Senior Leadership At White House, FDA: But Retail Stays Bearish
During the meeting with the White House, the company highlighted the need for advanced treatments for acute radiation syndrome in the United States and its allied countries.
Stocktwits·5mo ago
News Placeholder
Tivic Health Names Biotech Industry Veteran Michael K. Handley to Executive Leadership Team
Tivic Health Systems, Inc. (Nasdaq: TIVC), a diversified therapeutics company, announced today that Michael K. Handley, formerly Chief Executive Officer, President and Chairman of Statera Biopharma...
Business Wire·7mo ago
News Placeholder
Real Good Food Stock Dives On Nasdaq Delisting: Retail Mood Sours
The company warned that trading may ultimately move to OTC’s “Expert Market,” where quotes for the company’s common stock will no longer be available for public viewing.
Stocktwits·8mo ago
News Placeholder
CEO Letter to Shareholders Issued by Tivic Health
Tivic Health Systems, Inc. (Nasdaq: TIVC), a health tech company developing and commercializing bioelectronic medicine, today released its annual CEO letter to shareholders. Dear Fellow Shareholders...
Business Wire·9mo ago
News Placeholder
Tivic Reports Third Quarter 2024 Financial Results and Provides Business Update
Tivic Health Systems, Inc. (Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, today announced third quarter and nine-months ended September, 30, 2024...
Business Wire·10mo ago
News Placeholder
Enrollment Complete in Tivic Health Optimization Study for its Non-Invasive Vagus Nerve Stimulation Device
Tivic Health Systems, Inc. (Nasdaq: TIVC), a health tech company developing and commercializing bioelectronic medicine, announced today that full enrollment has been completed in the optimization...
Business Wire·10mo ago
News Placeholder
Tivic Health Validates European Patents in Great Britain, Germany, and France
Tivic Health Systems, Inc. (Nasdaq: TIVC), a health tech company developing and commercializing bioelectronic medicinal devices, announced today that it has validated two granted European Patent...
Business Wire·10mo ago
News Placeholder
Tivic Health Systems, Inc. to Report Third Quarter 2024 Financial Results on November 14
Tivic Health Systems, Inc. (Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, today announced it will report financial results on Thursday, November 14...
Business Wire·10mo ago

Latest TIVC News

View

Advertisement. Remove ads.

Advertisement. Remove ads.